BioLife Solutions - נכסים נקיים למניה בודדת BLFS

BioLife Solutions, Inc. (BLFS) develops intelligent containers and biopreservation environments, ensuring the integrity of valuable samples during transport. Serving as the primary valuation tool, this price chart demonstrates the asset's dynamics, where the key indicator is 8.53. The business provides cryogenic support for oncology therapies, while high margins in the genetic engineering sector support a steady cash flow and liquidity.

Developing automated cryopreservation systems requires significant capital expenditures in the technological infrastructure of BioLife Solutions, Inc. (BLFS). Book value per share is calculated as the difference between total assets and liabilities, divided by the number of outstanding shares. This metric determines the intrinsic value of the business, stripped of market volatility. An increase in this indicator signals the effective accumulation of equity. The historical book value per share data visualizes this fundamental trend.